Yd. Jin et al., THE IMMUNE REACTIVITY ROLE OF HCV-INDUCED LIVER INFILTRATING LYMPHOCYTES IN HEPATOCELLULAR DAMAGE, Journal of clinical immunology, 17(2), 1997, pp. 140-153
Liver infiltrating lymphocytes (LIL) were isolated from HCV-positive (
+) and HCV-negative (-) end-stage livers. Phenotypic analysis and func
tional studies using proliferative and lymphocytotoxic assays were per
formed with the isolated LIL. Two CD3+ lymphocyte populations were fou
nd in LIL using FITC anti-CD3 monoclonal antibodies (mAb), One was a b
right fluorescence intensity population (as in PBL), and the other dim
. We calculated the number of FITC-anti-CD3 mAbs bound per lymphocyte
on PBL and LV, and found 80,040 +/- 4628 and 39.615 +/- 3932, respecti
vely. Therefore, HCV+ and HCV- patient PBL contained approximately twi
ce the number of CD3 molecules per cell than patient CD3+ LIL. LIL als
o contained approximately a threefold higher concentration of TCR alph
a beta+, CD4-CD8-, and CD56,16 (NK) cells than the patient PBL. Thus,
a major subset of LIL is phenotypically similar to mouse NK1.1+ ''inte
rmediate'' T cells. LIL freshly isolated from HCV+ livers exhibited we
ak CTL activity against EBV- or Con A-transformed lymphoblast targets
infected with vaccinia-HCV recombinant virus (rHCV) or primary hepatoc
yte cultured cells. However, after in vitro a coculture of LIL with rH
CV, these cells developed a strong cytotoxicity for the above targets.
In contrast, LIL from HCV-livers were not cytotoxic against the same
targets. Histochemical studies (in situ) demonstrated that these hepat
ocytes express CD95, and stains demonstrated apoptosis. The HCV+ hepat
ocytes also express class I MHC molecules and ICAM-1. The addition of
mAb specific for these adhesion molecules inhibited CML activity. Shor
t-term cultured hepatocytes (targets) from HCV+ and HCV- patients prod
uced low levels of cytokines IL-1 beta, IL-2, IL-6, TNF alpha, and IFN
-gamma but a high level of IL-8. It is speculated that LIL expressing
reduced numbers of CD3 molecules may even function as immune regulator
s as proposed for intermediate T cells in mice.